Question 1

What are the potential side effects of QH103 compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma clinical trial (NCT07367685). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the lymphodepletion process work, and what should I expect during that time?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma clinical trial (NCT07367685). Contact the study team or your healthcare provider for specific answers.

Question 3

What criteria will be used to determine if I am eligible for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma clinical trial (NCT07367685). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma clinical trial (NCT07367685). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma clinical trial (NCT07367685). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any other treatment options I should consider alongside this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma clinical trial (NCT07367685). Contact the study team or your healthcare provider for specific answers.

What this study is about